Access Resources
1561 - 1570 of 7540 Results
Title
Year
- Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease2022RESTRICTEDTitle: Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1272End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28992Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28992Citation Count: 18
-
RESTRICTEDTitle: Editorial: LRRK2—Fifteen Years From Cloning to the ClinicJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.880914Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.880914/pdfCitation Count: 0
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease2022RESTRICTEDTitle: Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00300-3Best OA location URL: https://www.nature.com/articles/s41531-022-00300-3.pdfCitation Count: 12
- Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables2022RESTRICTEDTitle: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variablesJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4803End Page: 4809Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06061-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06061-4.pdfCitation Count: 13
-
RESTRICTEDTitle: Targeting KRAS G12C with Covalent InhibitorsJournal Name: Annual Review of Cancer BiologyPublisher: Annual ReviewsVol: 6Issue #: 1Start Page: 49End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1146/annurev-cancerbio-041621-012549Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-041621-012549Citation Count: 15
- Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration2022RESTRICTEDTitle: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegenerationJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e1010138End Page: e1010138Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1010138Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1010138&type=printableCitation Count: 2
- Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia Syndrome2022RESTRICTEDTitle: Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia SyndromeJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 8Start Page: 1276End Page: 1276Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11081276Best OA location URL: https://www.mdpi.com/2073-4409/11/8/1276/pdf?version=1649728209Citation Count: 8
- Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)2022RESTRICTEDTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 4
-
RESTRICTEDTitle: GBA Variants and Parkinson Disease: Mechanisms and TreatmentsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 8Start Page: 1261End Page: 1261Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells11081261Best OA location URL: https://www.mdpi.com/2073-4409/11/8/1261/pdf?version=1649400398Citation Count: 60
-
RESTRICTEDTitle: Wolframin is a novel regulator of tau pathology and neurodegenerationJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 143Issue #: 5Start Page: 547End Page: 569Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-022-02417-4Best OA location URL: https://discovery.ucl.ac.uk/10147233/1/ANEU-D-21-00876_R2.pdfCitation Count: 21